Pfizer-BioNTech to get EU 200 million more COVID-19 shots
Pfizer and BioNTech say they have reached an agreement to supply the European Union with another 200 million doses of their COVID-19 vaccine
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Pfizer and BioNTech said Wednesday they have reached an agreement to supply the European Union with another 200 million doses of their COVID-19 vaccine.
The U.S. and German companies said in a statement that the doses come on top of the 300 million initially ordered. The EU’s executive Commission has an option to request a further 100 million doses.
They said the 200 million doses are expected to be delivered this year, with an estimated 75 million of them in the second quarter.
The Pfizer-BioNTech vaccine was the first of three so far to be approved for use in the EU which faces criticism for a slow start to its vaccination campaign. The other two approved vaccines are from Moderna and AstraZeneca.